Biomedical Engineering Reference
In-Depth Information
123. Qin C, Du Y, Xiao L, Li Z, Gao X. Enzymic preparation of water-soluble chi-
tosan and their antitumor activity.
Int. J. Biol. Macromol.
2002; 31: 111-117.
124. Maeda Y, Kimura Y. Antitumor ef ects of various low-molecular-weight chi-
tosans are due to increased natural killer activity of intestinal intraepithelial
Lymphocytes in Sarcoma 180-bearing mice
. J Nutr.
2004; 134: 945-950.
125. Qi L, Xu Z. In vivo antitumor activity of chitosan nanoparticles
. Bioorg. Med.
Chem. Lett .
2006; 16: 4243-4245.
126. Qi L, Xu Z, Chen M. In vitro and in vivo suppression of hepatocellular car-
cinoma growth by chitosan nanoparticles.
Eur. J. Cancer
2007; 43: 184-193.
127. Hasegawa M, Yagi K, Iwakawa S, Hirai M. Chitosan induces apoptosis via
caspase-3 activation in bladder tumor cells.
Jpn. J. Cancer Res.
2001; 92:
459-466.
128. Takimoto H, Hasegawa M, Yagi K, Nakamura T, Sakaeda T, Hirai M.
Proapoptotic ef ect of a dietary supplement: Water soluble chitosan acti-
vates caspase-8 and modulating death receptor expression
. Drug Metab.
Pharmacokinet.
2004; 19: 76-82.
129. Xu Q, Dou J, Wei P, Tan C, Yun X, Wu Y, Bai X, Ma X, Du Y.
Chitooligosaccharides induce apoptosis of human hepatocellular carcinoma
cells via up-regulation of Bax.
Carbohydr. Polym.
2008; 71: 509-514.
130. Wang Y-C, Fu R-H, Hsieh H-J, Chao H-T, Kao S-H Polyglycolic acid/chito-
san glue and apoptosis of endometriotic cells.
Fertil. Steril
.2005; 84: 75-81
.
131. Hwang S-M, Chen C-Y, Chen
S-S, Chen J-C.
Chitinous materials inhibit
nitric oxide production by activated RAW 264.7 macrophages
. Biochem.
Biophys. Res. Commun.
2000; 271: 229-233.
132. Nam K-S, Kim M-K, Shon Y-H. Inhibition of proinl ammatory cytokine-
induced invasiveness of HT-29 cells by chitosan oligosaccharide.
J. Microbiol.
Biotechnol.
2007; 17: 2042-2045.
133. Yoon HJ, Moon ME, Park HS, Im SY, Kim YH. Chitosan oligosaccharide
(COS) inhibits LPS-induced inl ammatory ef ects in RAW 264.7 macro-
phage cells
. Biochem. Biophysl. Res. Commun.
2007; 358: 954-959.
134. Yoon HJ, Moon ME, Park HS, Kim HW, Im SY, Lee JH, Ho Y. Ef ects of chi-
tosan oligosaccharide (COS) on the glycerol-induced acute renal failure in
vitro and in vivo.
Food Chem. Toxicol.
2008; 46: 710-716.
135. Porporatto C, Bianco ID, Riera CM, Correa SG. Chitosan induces dif erent
L-arginine metabolic pathways in resting and inl ammatory macrophages.
Biochem. Biophys. Res. Commun.
2003; 304: 266-272.
136. Jeong HJ, Koo HN, Oh EY, Chae HJ, Kim HR, Suh SB, Kim CH, Cho KH,
Park BR, Park ST, Lee ST, Lee YM, Kim HM. Nitric oxide production by high
molecular weight watersoluble chitosan via nuclear factor-kappa B activa-
tion.
Int. J. Immunopharmacol.
2000; 22: 923-933.
137. Seo W-G, Pae H-O, Kim N-Y, Oh G-S, Park I-S, Kim Y-H, Kim Y-M, Lee
Y-H, Jun C-D, Chung H-T. Synergistic cooperation between water-soluble
chitosan oligomers and interferon-g for induction of nitric oxide synthesis
